论文部分内容阅读
目的浅析急诊内科中老年重症心力衰竭患者的临床治疗效果。方法回顾性分析2014年2月至2015年8月接受重症心力衰竭治疗的98例老年患者的临床资料,依据治疗方式不同分为实验组和对照组,实验组患者接受常规急诊内科治疗和美托洛尔+厄贝沙坦氢氯噻嗪药物治疗,对照组患者仅接受急诊内科常规治疗,分析两组患者治疗前后的NYHA、BNP、LVEF指标和临床效果。结果经过相应治疗两组患者的各项指标均得到改善,且实验组患者三项指标的改善程度要明显优于对照组(P<0.05);实验组患者的治疗总有效率(91.84%)明显高于对照组(81.63%)(P<0.05)。结论在对重症心力衰竭老年患者施行常规治疗的同时,给予患者美托洛尔+厄贝沙坦氢氯噻嗪药物治疗的临床效果显著,值得在临床中推广使用。
Objective To analyze the clinical effect of acute internal medicine in patients with severe heart failure in emergency department. Methods The clinical data of 98 elderly patients who underwent severe heart failure from February 2014 to August 2015 were retrospectively analyzed. According to the different treatment methods, the patients were divided into experimental group and control group. Patients in experimental group received routine emergency medical treatment and methotrexate Irbesartan Hydrochlorothiazide drug treatment, the control group of patients received only conventional treatment of emergency medicine, two groups of patients before and after treatment of NYHA, BNP, LVEF indicators and clinical effects. Results After treatment, the indexes of both groups were improved, and the improvement of the three indexes in the experimental group was obviously better than that in the control group (P <0.05). The total effective rate of the experimental group was 91.84% Higher than the control group (81.63%) (P <0.05). Conclusions In the elderly patients with severe heart failure conventional treatment, while giving metoprolol + irbesartan hydrochloride hydrochlorothiazide drug treatment of clinical effect is significant, it is worth promoting in the clinic.